• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2007 Fiscal Year Final Research Report Summary

Novel signal transduction pathways in constitutive active mutants of receptor tyrosine kianses

Research Project

Project/Area Number 18591058
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionOsaka University

Principal Investigator

MIZUKI Masao  Osaka University, Hospital, Associate Professor (80283761)

Co-Investigator(Kenkyū-buntansha) KANAKURA Yuzuru  Osaka Univetsty, Graduate School of Medicine, Professor (20177489)
MATSUMURA Itaru  Osaka Univetsty, Graduate School of Medicine, Associate Professor (00294083)
SHIBAYAMA Hirohiko  Osaka Univetsty, Graduate School ofMedicine, Assistant Professor (60346202)
Project Period (FY) 2006 – 2007
Keywordsc-Kit / FLT3 / AML / signal transduction / STAT
Research Abstract

Constitutive active mutants of receptor tyrosine kinases such as c-Kit and FLT3 have been identified as the frequent genetic abnormalities in acute myeloid leukemia, which serve as possible therapeutic targets. We have made a series of single Tyr-Phe mutants of c-Kit and FLT3, either wild type or active mutants, and analysed the critical signal transduction pathways which lead to cell function and oncogenic transformation. By analyzing the Tyr-Phe mutations of each 22 tyrosine residue of c-Kit, we have identified that Tyr567, Tyr569, and Tyr719 are the critical tyrosine residues which regulated the chemotactic function of c-Kit. Tyr567 and Tyr719 activates Src family kinases (SFK) and PI3K respectively, which cooperatively regulate the c-Kit/SCF mediated chemotaxis. By analyzing Gab2 (-/-) mast cells, we find that Gab2 is required for SCF-evoked proliferation, activation of Rac/JNK, and Ras. In wild type c-Kit, Tyr567 mediates SFK binding, and SFK activity was required for Gab2 tyrosyl phosphorylation and association with Shp-2. Thus, we find that Gab2, which is the downstream signaling intermediate of Tyr567, regulates c-Kit/SCF-mediated cellular function. In constitutive active mutants, STAT3/5 is highly activated compared to wild type. The mechanism of this aberrant activation has not been clarified. As FLT3 has three consensus STAT3 binding motifs in cytoplasmic domain, we have analysed the involvement of these tyrosine residues in the activation of STAT3 by FLT3 Asp835Val. In FLT3 Asp835Val, the Tyr-Phe conversion of these three tyrosine residues diminished, but not completely abolished the STAT3 activation. This result suggests that in constitutive active mutants of receptor tyrosine kinases, the aberrant STAT activation still partially depends on the binding to the consensus motif sequence, but also on the surrogate activation pathways such as src familily kinase pathways, which may be mediated by the juxtamembrane region and Gab2.

  • Research Products

    (10 results)

All 2008 2007 2006

All Journal Article (7 results) (of which Peer Reviewed: 3 results) Presentation (2 results) Book (1 results)

  • [Journal Article] Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies2008

    • Author(s)
      Matsumura I, et. al.
    • Journal Title

      Cancer Science 99

      Pages: 479-485

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies2008

    • Author(s)
      Matsumura, I, et. al.
    • Journal Title

      Cancer Sci 99(3)

      Pages: 479-485

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] An indolent subtype of "intravascular lymphoma": A case with a 3-year history of LDH elevation2007

    • Author(s)
      Ishiko J, et. al.
    • Journal Title

      Leuk Lymphoma 48

      Pages: 1872-1874

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] An indolent subtype of "intravascular lymphoma" : A case with a 3-year history of LDH elevation2007

    • Author(s)
      Ishiko, J, et. al.
    • Journal Title

      Leuk Lymphoma 48

      Pages: 1872-1874

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Chronic myeloid leukemia2007

    • Author(s)
      Mizuki, M, et. al.
    • Journal Title

      Internal Medicine 9th edition (Sugimoto T & Yazaki Y ed.) Asakura Publishing Co., Ltd

      Pages: 1656-1659

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway2006

    • Author(s)
      Yu M, et. al.
    • Journal Title

      J Biol Chem. 281

      Pages: 28615-28626

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway2006

    • Author(s)
      Yu, M, Luo, J, et. al.
    • Journal Title

      J Biol Chem 281

      Pages: 28615-28626

    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] 腫瘍性チロシンキナーゼによる病型決定機構:FIP1L1/PDGFRαによる好酸球系細胞への選択的誘導2007

    • Author(s)
      福島健太郎
    • Organizer
      第69回日本血液学会・第49回日本臨床血液学会合同総会
    • Place of Presentation
      横浜
    • Year and Date
      2007-10-11
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] FIP1L1/PDGFRa imposes commitment towards eosinophil lineage on hematopoietic stem/progenitor cells by modifying the expression and function of lineage specific transcription factors2007

    • Author(s)
      Fukushima, K, et. al.
    • Organizer
      The 69th Annual meeting of the Japanese Hematology Society and the 49th Annual meeting of the Japanese Society of Clinical Hematology
    • Place of Presentation
      Yokohama
    • Year and Date
      2007-10-11
    • Description
      「研究成果報告書概要(欧文)」より
  • [Book] 「慢性骨髄性白血病」 内科学 第9版(杉本恒明, 矢崎義雄編)2007

    • Author(s)
      水木満佐央
    • Total Pages
      1656-1659
    • Publisher
      朝倉書店
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2010-02-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi